For patients taking GLP-1 receptor agonists such as semaglutide or dulaglutide, there is currently no evidence suggesting that allulose interferes with medication efficacy or causes adverse interactions
Make sure to protect the injection from direct light and keep it away from children
As of June 2025, the branded version of liraglutide, Saxenda, generated $165 million in annual sales alone, and the market for GLP-1s could be set to hit over $126 billion in sales by 2029
This represents the cash-pay price for the FDA-approved, brand-name product
I always feel like Im in great hands and look forward to my bi-weekly IVs
Frontiers in Endocrinology, 16 , 1605746